Lactancia materna en México

by David Kershenobich
Published 2017-05-01

Indications and contraindications for treatment of hepatitis C virus infections

by David Kershenobich
Published 2006-01-01

Treatment of HCV infected patients and renal disease

by David Kershenobich
Published 2010-01-01

The National Institute of Medical Sciences and Nutrition Salvador Zubirán: A Brief Journey Through its History

by David Kershenobich-Stalnikowitz
Published 2021-01-01

Presentation

by David Kershenobich, Teresa Shamah-Levy
Published 2018-05-01

Preface

by Alfredo Ulloa-Aguirre, David Kershenobich-Stalnikowitz
Published 2021-01-01

Amebic liver abscess

by Aldo Torre, MD, David Kershenobich, MD PhD
Published 2002-01-01

Liver fibrosis and inflammation. A review

by David Kershenobich Stalnikowitz, MD, PhD, Alan Bonder Weissbrod, Dr. MD
Published 2003-10-01

The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population

by Leonardo A. Martínez, Elena Larrieta, Juan J. Calva, David Kershenobich, Aldo Torre
Published 2017-11-01

Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? Seroprevalence of hepatitis C among Mexican adults: an emerging public healt...

by José Luis Valdespino, Carlos J Conde-González, Gustavo Olaiz-Fernández, Oswaldo Palma, David Kershenobich, Jaime Sepúlveda
Published 2007-01-01

Los criterios de elegibilidad actuales del Seguro Popular para recibir tratamiento para el virus de la hepatitis C

by Carlos Moctezuma-Velázquez, Juan Francisco Sánchez-Ávila, Ignacio García-Juárez, Luis Federico Uscanga-Domínguez, David Kershenobich-Stalnikowitz
Published 2016-12-01

Acciones prioritarias para un programa nacional de detección, tratamiento y seguimiento de pacientes con hepatitis C

by Enrique Wolpert-Barraza, Onofre Muñoz-Hernández, David Kershenobich-Stalnikowitz, Coalición para el estudio de la hepatitis C en México
Published 2019-03-01

Alterations in Activation, Cytotoxic Capacity and Trafficking Profile of Peripheral CD8 T Cells in Young Adult Binge Drinkers.

by José Luis Zaldivar Fujigaki, América Guadalupe Arroyo Valerio, Juan Carlos López Alvarenga, Esperanza Gabriela Gutiérrez Reyes, David Kershenobich, Joselin Hernández Ruiz
Published 2015-01-01

Efficacy of triple therapy with thymalfasin, peginterferon α-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders

by Jorge L. Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocío Torres-Ibarra, Julieta Góngora, Carlos Cano, Miguel Parada, Misael Uribe
Published 2008-10-01

Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes

by Enrique O Graue-Hernandez, David Rivera-De-La-Parra, Sergio Hernandez-Jimenez, Carlos A Aguilar-Salinas, David Kershenobich-Stalnikowitz, Aida Jimenez-Corona
Published 2020-10-01

Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico.

by Braulio A Marfil-Garza, Pablo F Belaunzarán-Zamudio, Alfonso Gulias-Herrero, Antonio Camiro Zuñiga, Yanink Caro-Vega, David Kershenobich-Stalnikowitz, José Sifuentes-Osornio
Published 2018-01-01

Main clinical factors influencing early mortality in a cohort of patients with severe alcoholic hepatitis, and evaluation trough ROC curves of different prognostic scoring systems

by Fátima Higuera-de la Tijera, Alfredo Israel Servín-Caamaño, Eduardo Pérez-Torres, Francisco Salas-Gordillo, Juan Miguel Abdo-Francis, José Luis Pérez-Hernández, David Kershenobich
Published 2014-10-01

Submuestra para el análisis de enfermedades crónicas con biomarcadores, Encuesta Nacional de Salud y Nutrición 2016

by Cesar Hernández-Alcaraz, Teresa Shamah-Levy, Martín Romero-Martínez, Jaime Sepúlveda-Amor, Carlos A. Aguilar-Salinas, Juan A. Rivera-Dommarco, David Kershenobich-Stalnikowitz, Mauricio Hernández-Ávila, Simón Barquera
Published 2020-08-01

High HPgV replication is associated with improved surrogate markers of HIV progression.

by Gibran Horemheb-Rubio, Pilar Ramos-Cervantes, Hugo Arroyo-Figueroa, Santiago Ávila-Ríos, Claudia García-Morales, Gustavo Reyes-Terán, Galileo Escobedo, Gloria Estrada, Trinidad García-Iglesias, Nayeli Muñoz-Saucedo, David Kershenobich, Patricia Ostrosky-Wegman, Guillermo M Ruiz-Palacios
Published 2017-01-01

Behavior of Oxidative Stress Markers in Alcoholic Liver Cirrhosis Patients

by Marina Galicia-Moreno, Dorothy Rosique-Oramas, Zaira Medina-Avila, Tania Álvarez-Torres, Dalia Falcón, Fátima Higuera-de la tijera, Yadira L. Béjar, Paula Cordero-Pérez, Linda Muñoz-Espinosa, José Luis Pérez-Hernández, David Kershenobich, Gabriela Gutierrez-Reyes
Published 2016-01-01